TotalMarketCap

Braveheart Bio

BRVENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.568 B

$17.42 -13.36%

Close of 6 Nov 2026

As of 6 Nov 2026, Braveheart Bio (BRVE) has a market capitalization of $1.57B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

90,038,969

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #109Ultragenyx PharmaceuticalRARE$1.58B
  2. #110Kailera TherapeuticsKLRA$1.58B
  3. #111Braveheart BioBRVE$1.57B
  4. #112NanobiotixNBTX$1.52B
  5. #113Nuvation BioNUVB$1.51B

What if Braveheart Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$313,607.25

Per share 18,003× higher

Bitcoin $1.53T

$16,968.74

Per share 974× higher

Apple $5.02T

$55,706.80

Per share 3,198× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Braveheart Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.